Argenx stock holds near records after Jefferies reiterates Buy

Published on 09/18/2026 at 14:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Argenx stock held at USD 999.06 on September 17, 2026, while Jefferies kept a USD 1,215 target. The latest EGM update came on September 17, 2026.

Fotorealistisches Laborpanorama: Wissenschaftler in weißen Kitteln begutachten leuchtende Antikörper-3D-Modelle auf Bildschirmen, Stahltische mit Laborgeräten im Hintergrund — Argenx NL0010832176 Forscher analysieren im modernen Biopharma-Labor leuchtende Antikörper-Strukturen auf großen Monitoren, Illustration mit AI erstellt.

Argenx stock (NL0010832176) traded at USD 999.06 on September 17, 2026, while Jefferies kept a USD 1,215 price target in a September 16, 2026 note. That leaves the shares about 17.2 percent below the target and near the top of their 52-week range.

Board changes and range

According to argenx, the company announced the results of its Extraordinary General Meeting on September 17, 2026, and appointed Thomas M. Brakel and Khurem Farooq as non-executive directors. The release was published at 22:01 PM CET.

The stock finished the session at USD 999.06 on Nasdaq, with a 52-week range of USD 661.85 to USD 1,072.75 and market capitalization of USD 62.50 billion, according to MarketBeat's September 17, 2026 snapshot. A move from USD 661.85 to USD 1,072.75 marks a trading band of 410.90 dollars.

Analyst view

As ad hoc news reported on September 17, 2026, Jefferies reiterated a Buy rating and left its Argenx target at USD 1,215. The same update said the shares closed at USD 1,001.50 on September 15, 2026, roughly one sixth below that level.

MarketBeat listed a consensus target of USD 1,158.61 on September 17, 2026, along with a Moderate Buy rating and 24 analysts covering the name. It also showed a trailing P/E of 38.22 and net margin of 32.19 percent.

Investor calendar

MarketBeat's company calendar showed the last earnings date as July 21, 2026, and a fiscal year end of December 31, 2026. The latest quarterly report reference on the same page showed EPS of USD 7.32 and revenue of USD 1.54 billion for the quarter ended July 21, 2026, with EPS above the USD 5.86 consensus by USD 1.46 and revenue above the USD 1.45 billion estimate by USD 0.09 billion.